Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.27T | 31.3x | 3.21 | SEK 1,475.50 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.8% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 110.66B | 31.6x | 2.34 | SEK 322.80 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
Sectra | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 53.99B | 141.5x | -10.96 | SEK 280.20 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3% Upside | Upgrade to Pro+ | |
Getinge B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 49.82B | 29.5x | -1.17 | SEK 183.70 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.6% Upside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 34.29B | 125.4x | -2.92 | SEK 585 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.2% Upside | Upgrade to Pro+ | |
Vitrolife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 29.76B | -7.8x | 0.01 | SEK 219.80 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.2% Upside | Upgrade to Pro+ | |
Medicover | Stockholm | Healthcare | Healthcare Providers & Services | SEK 28.83B | 130.3x | 0.87 | SEK 193.80 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.5% Upside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 26.30B | 288.8x | -4.97 | SEK 398.60 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.4% Upside | Upgrade to Pro+ | |
Elekta B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 23.22B | 23.2x | -0.91 | SEK 61.50 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.9% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 20.82B | 62,552.2x | 71.37 | SEK 40.20 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.1% Upside | Upgrade to Pro+ | |
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 18.49B | -79x | 0.4 | SEK 209.80 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AddLife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 17.27B | 147.6x | -2.44 | SEK 141.20 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.5% Upside | Upgrade to Pro+ | |
Xvivo Perfusion AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 16.10B | 77.8x | 0.11 | SEK 511 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.5% Upside | Upgrade to Pro+ | |
Biotage AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 13.01B | 50.6x | 2.6 | SEK 162.60 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.4% Upside | Upgrade to Pro+ | |
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 11.30B | 33.6x | -1.46 | SEK 111.40 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34% Upside | Upgrade to Pro+ | |
Arjo | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 9.93B | 19.7x | 0.68 | SEK 36.30 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.3% Upside | Upgrade to Pro+ | |
Implantica AG | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 9.74B | -35.4x | 1.46 | SEK 34.55 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ambea | Stockholm | Healthcare | Healthcare Providers & Services | SEK 8.16B | 14.1x | 0.16 | SEK 97.30 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.3% Upside | Upgrade to Pro+ | |
Surgical Science Sweden | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 8B | 41.5x | -1.78 | SEK 157 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Attendo International publ AB | Stockholm | Healthcare | Healthcare Providers & Services | SEK 7.97B | 20.6x | 0.41 | SEK 51.80 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.6% Upside | Upgrade to Pro+ | |
RaySearch Labs B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 7.63B | 43.5x | 0.24 | SEK 222.50 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.4% Upside | Upgrade to Pro+ | |
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 7.63B | 123.1x | -4.25 | SEK 48.20 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |
CellaVision AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 5.08B | 33.6x | 1.02 | SEK 211.50 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.8% Upside | Upgrade to Pro+ | |
Probi AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.98B | 364.4x | -17.95 | SEK 349 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.71B | -448.5x | SEK 47.55 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.8% Upside | Upgrade to Pro+ | ||
Medistim ASA | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.76B | 27.6x | -2.08 | SEK 144.44 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.74B | -6.7x | 0.21 | SEK 41.60 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.72B | -3.6x | -0.12 | SEK 40 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.53B | -6.4x | -0.38 | SEK 7.10 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BICO Group | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.31B | -1.3x | 0.12 | SEK 32.74 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |